Examiners Amendment

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

EXAMINER’S AMENDMENT

Issue date:  December 11, 2020

Application has been amended as shown below.  As agreed to by Quincy Kayton, applicant’s attorney, on December 11, 2020, the examining attorney has amended the application as shown below.  Please notify the examining attorney immediately of any objections. TMEP §707.  Otherwise, no response is required.  Id.  In addition, applicant is advised that amendments to the goods and services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and services are not permitted.  37 C.F.R. §2.71(a).

Identification of Goods and Services Amended.  The identification of goods and services is amended to read as follows:

Class 1: Assays for scientific and research purposes; assays for biomarker verification, validation, and application; assays for use in connection with mass spectrometry

Class 9: Downloadable or recorded software for informatics, bioinformatics; Downloadable or recorded software for clinical trial data acquisition, validation, and analysis; Downloadable or recorded software for cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; Downloadable or recorded software for managing information related to clinical trials

Class 42: Scientific research and development; Medical research and development; Product research and development; Biochemical research and development; Pharmaceutical research and development services; Biomedical research and development services; Design and development of biochemical, pharmaceutical, and medical assays; Scientific and pharmaceutical research in the field of biomarker discovery; Scientific research and development in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; immune monitoring, and genetic profiling for research and development purposes; scientific research and development in the field of mass cytometry, cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; providing laboratory testing services in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, pathology, histopathology; Conducting clinical trials for others; Conducting clinical trials for others in the fields of pharmaceutical, medical, and scientific research; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Conducting research and clinical trials for others in the fields of oncology, infectious diseases, autoimmune disorders, and allergies; Consulting services in the field of clinical trial research; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Laboratory research services relating to pharmaceuticals; Software as a service (SAAS) services featuring software for informatics, bioinformatics; software as a service (SAAS) services featuring software for clinical trial data acquisition, validation, and analysis; Software as a service (SAAS) services featuring software for cellular analysis, cell sorting, pathway phenotyping, and molecular surface profiling; Software as a service (SAAS) services featuring software for cell cytometry; Software as a service (SAAS) services featuring software for managing information related to clinical trials

Class 44: Genetic testing for medical purposes; Consulting services in the fields of diagnostic medical testing; Medical testing for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; immune monitoring, and genetic profiling for medical and diagnostic purposes

Class 45: Regulatory compliance consulting in the fields of pharmaceuticals and clinical diagnostics; Advice and consultancy on food, drug, and medical device regulatory matters; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical device

See TMEP §§1402.01, 1402.01(e).

/Olivia S. Lee/

Olivia S. Lee

Trademark Examining Attorney

Law Office 128

olivia.lee@uspto.gov

(571) 272-6848

United States Patent and Trademark Office (USPTO)

USPTO OFFICIAL NOTICE

Office Action (Official Letter) has issued

on December 11, 2020 for

U.S. Trademark Application Serial No. 90112472

Your trademark application has been reviewed by a trademark examining attorney.  As part of that review, the assigned attorney has issued an official letter.  Please follow the steps below.

(1)  Read the official letter.  No response is necessary.

(2)  Direct questions about the contents of the Office action to the assigned attorney below. 

/Olivia S. Lee/

Olivia S. Lee

Trademark Examining Attorney

Law Office 128

olivia.lee@uspto.gov

(571) 272-6848

Direct questions about navigating USPTO electronic forms, the USPTO website, the application process, the status of your application, and/or whether there are outstanding deadlines or documents related to your file to the Trademark Assistance Center (TAC).

GENERAL GUIDANCE

·         Check the status of your application periodically in the Trademark Status & Document Retrieval (TSDR) database to avoid missing critical deadlines.

·         Update your correspondence email address, if needed, to ensure you receive important USPTO notices about your application.

·         Beware of misleading notices sent by private companies about your application.  Private companies not associated with the USPTO use public information available in trademark registrations to mail and email trademark-related offers and notices – most of which require fees.  All official USPTO correspondence will only be emailed from the domain “@uspto.gov.”